2025 EU HTA: Launching a New Era in Joint Clinical Assessments
January 12th marked the launch of Joint Clinical Assessment (JCA), a key milestone in the
January 12th marked the launch of Joint Clinical Assessment (JCA), a key milestone in the
What is NTAP The New Technology Add-On Payment (NTAP) is a reimbursement program under the
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
The implementation of the Joint Clinical Assessment (JCA) in the European Union represents a notable
On July 4, 2024, the Bundestag (German Parliament) passed significant amendments to the country’s drug
What you need to know about confidential discounts and net prices in EU-5 In the
Justin Stindt Consultants is a fast growing consulting company offering strategy & market access consulting services to leading pharmaceutical, biotech and medical device clients. We operate in Europe and the United States.
